ADHD related Press Releases
PRESS RELEASE: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive... Read more...
FDA STATEMENT: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications
AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive... Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
